Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC each year through CY 2014, and then is fixed at 2 percent for later years. For more information on the e-prescribing provisions of the MIPPA, please see section 132 of the MIPPA legislation enacted on July 15, 2008 (Pub. L. 110-275, http://frwebgate.access.gpo.gov/cgi- bin/getdoc.cgi?dbname=110_cong_public_laws&docid=f:publ275. 110.pdf). We envision that the MIPPA-created incentive payments for those prescribers who successfully implement electronic prescribing in accordance with MIPPA guidelines will provide the “tipping point” - an adequate level of industry adoption of e-prescribing using electronic data interchange (EDI) that would in turn move the entire industry toward widespread e-prescribing adoption. We believe that data from the e-prescribing incentive program under the MIPPA and eventually from Part D e-prescribing will offer evidence of the rate of e-prescribing adoption, therefore making a study of e-prescribing for purposes of determining e-prescribing adoption rates unnecessary. We analyzed the industry feedback that we received in response to the computer-generated facsimile exemption proposals in the CY 2009 PFS proposed rule in light of the recent MIPPA legislation. While the MIPPA legislation was not yet been enacted at the time of the CY 2009 PFS 338
CMS-1403-FC proposed rule's publication, it was enacted in time for commenters to discuss its provisions in their comments to our proposals. Based on MIPPA-based and other comments received in response to our proposal to further modify the computer-generated facsimile exemption, and taking into consideration the potential positive impact on the industry of the Part D e-prescribing incentives included in the recently-enacted MIPPA legislation, we are reinstating the original exemption for computer-generated facsimiles effective January 1, 2009. We also agree with those commenters who suggested that the computer-generated facsimile exemption should be eliminated (in all instances other than transient/temporary network transmission failures) once provider e-prescribing disincentives under the MIPAA program are initiated. Although several commenters suggested that we should wait until the disincentives are maximized in 2014, we feel that it is more appropriate to eliminate the reinstated exemption (in all instances other than temporary/transient network transmission problems) sooner, when the MIPPA e-prescribing program disincentives for those who are not successful electronic prescribers begin in 2012. We believe that the January 1, 2012 compliance date for the elimination of the computer-generated facsimile exemption 339
- Page 287 and 288: CMS-1403-FC determination. Specific
- Page 289 and 290: CMS-1403-FC individual practitioner
- Page 291 and 292: CMS-1403-FC determines in February
- Page 293 and 294: CMS-1403-FC Management Manual (IOM
- Page 295 and 296: CMS-1403-FC Response: Based on thes
- Page 297 and 298: CMS-1403-FC or continues to meet th
- Page 299 and 300: CMS-1403-FC to identify and discipl
- Page 301 and 302: CMS-1403-FC Response: We disagree w
- Page 303 and 304: CMS-1403-FC save our severe penalti
- Page 305 and 306: CMS-1403-FC Response: We disagree w
- Page 307 and 308: CMS-1403-FC affords the supplier ap
- Page 309 and 310: CMS-1403-FC privileges and assess a
- Page 311 and 312: CMS-1403-FC §424.535(a)(10) that w
- Page 313 and 314: CMS-1403-FC documentation for 7 yea
- Page 315 and 316: CMS-1403-FC pharmacies to follow re
- Page 317 and 318: CMS-1403-FC Comment: One commenter
- Page 319 and 320: CMS-1403-FC practitioners, includin
- Page 321 and 322: CMS-1403-FC that require a revoked
- Page 323 and 324: CMS-1403-FC provider and supplier e
- Page 325 and 326: CMS-1403-FC K. Amendment to the Exe
- Page 327 and 328: CMS-1403-FC Prescription Fill Statu
- Page 329 and 330: CMS-1403-FC dispensers to move towa
- Page 331 and 332: CMS-1403-FC Following the publicati
- Page 333 and 334: CMS-1403-FC does not respond to the
- Page 335 and 336: CMS-1403-FC facsimiles in all insta
- Page 337: CMS-1403-FC Similarly, other commen
- Page 341 and 342: CMS-1403-FC elimination of the comp
- Page 343 and 344: CMS-1403-FC exemption originally cr
- Page 345 and 346: CMS-1403-FC dispensers are not requ
- Page 347 and 348: CMS-1403-FC products, or, where upg
- Page 349 and 350: CMS-1403-FC take time to develop, a
- Page 351 and 352: CMS-1403-FC integrated this technol
- Page 353 and 354: CMS-1403-FC Version 10.2 or higher)
- Page 355 and 356: CMS-1403-FC proposed January 2009 c
- Page 357 and 358: CMS-1403-FC L. Comprehensive Outpat
- Page 359 and 360: CMS-1403-FC examination. In order t
- Page 361 and 362: CMS-1403-FC qualifications for HHAs
- Page 363 and 364: CMS-1403-FC distinction in the lice
- Page 365 and 366: CMS-1403-FC (2) Have successfully c
- Page 367 and 368: CMS-1403-FC risk-taking behaviors,
- Page 369 and 370: CMS-1403-FC Therefore, we proposed
- Page 371 and 372: CMS-1403-FC commenter stated that o
- Page 373 and 374: CMS-1403-FC psychological services
- Page 375 and 376: CMS-1403-FC 3. CORF Conditions of P
- Page 377 and 378: CMS-1403-FC Therefore, we proposed
- Page 379 and 380: CMS-1403-FC Therefore, we proposed
- Page 381 and 382: CMS-1403-FC The following is a summ
- Page 383 and 384: CMS-1403-FC We are not making any c
- Page 385 and 386: CMS-1403-FC N. Physician Self-Refer
- Page 387 and 388: CMS-1403-FC arrangements, and the l
<strong>CMS</strong>-1403-FC<br />
proposed rule's publication, it was enacted in time for<br />
commenters to discuss its provisions in their comments to<br />
our proposals. Based on MIPPA-based and other comments<br />
received in response to our proposal to further modify the<br />
computer-generated facsimile exemption, and taking into<br />
consideration the potential positive impact on the industry<br />
of the Part D e-prescribing incentives included in the<br />
recently-enacted MIPPA legislation, we are reinstating the<br />
original exemption for computer-generated facsimiles<br />
effective January 1, 2009. We also agree with those<br />
commenters who suggested that the computer-generated<br />
facsimile exemption should be eliminated (in all instances<br />
other than transient/temporary network transmission<br />
failures) once provider e-prescribing disincentives under<br />
the MIPAA program are initiated.<br />
Although several commenters suggested that we should<br />
wait until the disincentives are maximized in 2014, we feel<br />
that it is more appropriate to eliminate the reinstated<br />
exemption (in all instances other than temporary/transient<br />
network transmission problems) sooner, when the MIPPA<br />
e-prescribing program disincentives for those who are not<br />
successful electronic prescribers begin in 2012. We<br />
believe that the January 1, 2012 compliance date for the<br />
elimination of the computer-generated facsimile exemption<br />
339